Product
ZVS203e
1 clinical trial
1 indication
Indication
Retinitis PigmentosaClinical trial
A Single-arm, Open-label Exploratory Clinical Study to Assess the Preliminary Safety of the Gene Editing Drug ZVS203e for the Management of Retinitis Pigmentosa Caused by Mutations in the RHO GeneStatus: Recruiting, Estimated PCD: 2026-04-01